Memantine and Comprehensive, Individualized Management of Alzheimer's Disease and Caregiver Training
Status:
Completed
Trial end date:
2011-11-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether a comprehensive, individualized management
approach with caregiver training and medication with memantine will alleviate symptoms in
community dwelling patients with moderate to severe Alzheimer's disease.
Phase:
Phase 4
Details
Lead Sponsor:
New York University School of Medicine NYU Langone Health
Collaborators:
Fisher Center for Alzheimer's Research Foundation Forest Laboratories